Tony Chen's practice focuses on patent litigation and portfolio management, technology licensing, R&D collaborations, and strategy counseling. He has advised Suzhou BioBay on the development of its biopharmaceutical industry as well as Shanghai Pudong New Area. Between 2010 and 2012, he co-chaired the IP subcommittee of the American Chamber of Commerce in Shanghai. [+]
This is a discussion about the above article. Concerns about the topic, its accuracy, inclusion of information etc. should be discussed here. Off-topic discussion not pertaining to the topic of the page will be removed.